Pure Biologics S.A. (WSE: PUR)

Pure Biologics Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	67	42	52	175	184	56
Market Cap Growth	73.32%	-18.86%	-70.44%	-4.91%	226.98%	136.98%
Enterprise Value	80	73	38	140	183	55
Last Close Price	18.20	12.64	23.00	77.80	111.50	34.10
PS Ratio	147.94	442.77	78.31	690.40	322.41	31.76
PB Ratio	-15.81	22.22	2.83	4.44	-63.88	11.02
P/TBV Ratio	-	25.71	2.88	4.48	-	11.65
P/FCF Ratio	-	-	-	-	-	8.49
P/OCF Ratio	-	-	-	-	-	8.16
EV/Sales Ratio	255.38	766.32	58.12	549.99	319.15	31.02
EV/FCF Ratio	-	-	-	-	-	8.30
Debt / Equity Ratio	-2.76	6.83	0.16	0.08	-1.73	1.05
Debt / FCF Ratio	-	-	-	-	-	0.81
Asset Turnover	0.01	0.00	0.02	0.01	0.03	0.13
Quick Ratio	0.59	2.30	1.74	7.61	0.57	1.21
Current Ratio	0.67	2.70	1.88	7.75	0.72	1.23
Return on Equity (ROE)	-853.92%	-353.58%	-88.62%	-64.29%	-1053.88%	-114.32%
Return on Assets (ROA)	-51.07%	-67.53%	-38.47%	-19.82%	-36.09%	-17.49%
Return on Capital (ROIC)	-61.43%	-104.60%	-48.39%	-29.32%	-114.55%	-37.78%
Earnings Yield	-43.15%	-84.86%	-49.39%	-6.71%	-6.37%	-7.44%
FCF Yield	-13.20%	-55.72%	-44.65%	-14.09%	-1.04%	11.77%
Buyback Yield / Dilution	13.76%	-41.50%	-1.48%	-34.29%	-8.48%	-38.63%
Total Shareholder Return	13.76%	-41.50%	-1.48%	-34.29%	-8.48%	-38.63%

Source: S&P Capital IQ. Standard template. Financial Sources.